Hidden toxins found in popular CBD oils, raising safety concerns

Unmasking hazardous compounds in cannabidiol-containing oils using planar bioassays and high-resolution mass spectrometry.

Talanta • • Moderately Relevant
🤖

AI Summary

CBD oils have become increasingly popular consumer products marketed for their potential health benefits, but this study reveals a troubling reality: many CBD oils contain hazardous compounds beyond just cannabinoids. Researchers analyzed 13 commercial CBD oil products using advanced laboratory techniques and discovered the presence of antimicrobial compounds, hormone-disrupting chemicals, neurotoxins, and even cancer-causing substances. These harmful compounds included phthalates (plastic additives with estrogenic properties), the mycotoxin zearalenone (which can cause genetic damage and mutations), and various oxidized compounds that formed during oil production or storage.

The research employed cutting-edge high-performance thin-layer chromatography combined with planar bioassays—specialized biological tests that can detect 13 different types of toxicological effects simultaneously—followed by high-resolution mass spectrometry to identify exactly what chemicals were present. This comprehensive approach allowed scientists to detect not just known contaminants but also unknown hazardous substances that triggered biological warning signs. The concerning finding is that these problematic compounds appear in the final products that consumers purchase, suggesting potential gaps in manufacturing quality control and contamination prevention.

Most significantly, the researchers demonstrated that this critical safety testing can now be performed affordably using a miniaturized, open-source laboratory device called 2LabsToGo-Eco, making it accessible for independent verification. This development is crucial because it means smaller labs, regulatory agencies, and consumer groups worldwide can conduct effect-directed screening of CBD products to identify hazardous contaminants. The findings underscore the urgent need for better industry standards, regulatory oversight, and consumer awareness regarding the hidden compounds lurking in seemingly "natural" CBD oils.

📄 Original Abstract

Oils containing cannabidiol (CBD) produced from Cannabis sativa L. became popular due to their health benefits. They contain not only known but also unknown active compounds. Hence, for the first time, an effect-directed non-target screening of 13 CBD oils for hazardous compounds was performed using high-performance thin-layer chromatography coupled with highly efficient duplex and multiplex planar bioassays, providing 13 different biological or toxicological endpoints. Antimicrobial (against Gram-positive/-negative bacteria), anti-/estrogenic, anti-/androgenic, cytotoxic (against Saccharomyces and three different Salmonella strains), neurotoxic/-modulating, genotoxic, and mutagenic compounds were found in the CBD oils. Selected hazardous substance zones were automatically eluted from the chromatogram and analyzed by high-resolution mass spectrometry. The tentatively assigned hazardous substances were bought as reference standards, co-analyzed, and confirmed to be various cannabinoids, assumedly oxidized acylglycerides, the estrogenic contaminants dibutyl phthalate and diisobutyl phthalate, and the estrogenic and mutagenic mycotoxin zearalenone, including metabolites. For more sustainability, the CBD oil analysis was successfully performed with the miniaturized open-source 2LabsToGo-Eco, which makes effect-directed non-target screening affordable for everyone.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.